CMRX Chimerix, Inc. Stock Quote

CMRX [NASD]

Index	-	P/E	-	EPS (ttm)	-1.82	Insider Own	4.40%	Shs Outstand	86.33M	Perf Week	-7.09%
Market Cap	544.22M	Forward P/E	-	EPS next Y	-0.28	Insider Trans	-61.54%	Shs Float	82.78M	Perf Month	12.81%
Income	-145.40M	PEG	-	EPS next Q	-0.34	Inst Own	62.60%	Short Float	3.32%	Perf Quarter	-17.48%
Sales	3.10M	P/S	175.55	EPS this Y	65.50%	Inst Trans	9.11%	Short Ratio	3.18	Perf Half Y	-24.55%
Book/sh	1.21	P/B	4.88	EPS next Y	81.10%	ROA	-111.10%	Target Price	18.00	Perf Year	59.89%
Cash/sh	1.33	P/C	4.44	EPS next 5Y	-	ROE	-135.00%	52W Range	3.38 - 11.57	Perf YTD	22.15%
Dividend	-	P/FCF	-	EPS past 5Y	23.50%	ROI	-60.60%	52W High	-49.00%	Beta	1.42
Dividend %	-	Quick Ratio	4.80	Sales past 5Y	-13.00%	Gross Margin	-	52W Low	74.56%	ATR	0.41
Employees	54	Current Ratio	4.90	Sales Q/Q	-93.80%	Oper. Margin	-	RSI (14)	48.21	Volatility	7.82% 7.98%
Optionable	Yes	Debt/Eq	0.13	EPS Q/Q	-17.30%	Profit Margin	-	Rel Volume	0.68	Prev Close	6.23
Shortable	Yes	LT Debt/Eq	0.00	Earnings	Nov 04 BMO	Payout	-	Avg Volume	864.23K	Price	5.90
Recom	1.70	SMA20	-0.35%	SMA50	-1.55%	SMA200	-22.62%	Volume	583,490	Change	-5.30%

Apr-29-21

Initiated

Maxim Group

Buy

$20

Apr-23-21

Resumed

Cowen

Outperform

$10 → $18

Mar-31-21

Initiated

Wedbush

Outperform

$21

Mar-31-21

Initiated

Jefferies

Buy

$21

Feb-14-18

Downgrade

JP Morgan

Neutral → Underweight

Feb-02-18

Initiated

H.C. Wainwright

Buy

$10

Aug-09-16

Reiterated

FBR Capital

Mkt Perform

$9 → $8

Feb-23-16

Reiterated

FBR Capital

Mkt Perform

$14 → $10

Feb-23-16

Downgrade

Morgan Stanley

Equal-Weight → Underweight

Feb-23-16

Downgrade

Barclays

Overweight → Equal Weight

$12 → $6

Feb-22-16

Downgrade

Citigroup

Buy → Neutral

Dec-29-15

Downgrade

JP Morgan

Overweight → Neutral

$65 → $15

Dec-28-15

Reiterated

Piper Jaffray

Overweight

$63 → $10

Dec-28-15

Downgrade

FBR Capital

Outperform → Mkt Perform

$73 → $14

Dec-17-15

Initiated

UBS

Buy

$55

Oct-05-15

Downgrade

Morgan Stanley

Overweight → Equal-Weight

Sep-03-15

Initiated

Citigroup

Buy

Aug-18-15

Initiated

FBR Capital

Outperform

$73

Aug-06-15

Reiterated

Brean Capital

Buy

$50 → $57

May-11-15

Reiterated

Brean Capital

Buy

$45 → $50

Nov-22-21 04:21AM	Is Chimerix (NASDAQ:CMRX) A Risky Investment? Simply Wall St.
Nov-19-21 07:00AM	Chimerix Announces Positive ONC201 Data in Recurrent H3 K27M-mutant Diffuse Midline Glioma to Be Presented at the Society for Neuro-Oncology Annual Meeting GlobeNewswire -5.83%
Nov-12-21 08:00AM	Chimerix to Present at Jefferies London Healthcare Conference GlobeNewswire
Nov-11-21 07:00AM	Chimerix Announces Upcoming Presentations at the Society for Neuro-Oncology Annual Meeting 2021 GlobeNewswire
Nov-04-21 08:03PM	Chimerix (CMRX) Q3 2021 Earnings Call Transcript Motley Fool
10:25AM	Chimerix (CMRX) Reports Q3 Loss, Lags Revenue Estimates Zacks
07:05AM	Chimerix Reports Third Quarter 2021 Financial Results and Provides Operational Update GlobeNewswire
07:00AM	Chimerix Announces Positive Topline Results for ONC201 in Recurrent H3 K27M-mutant Glioma GlobeNewswire
Nov-01-21 08:00AM	Chimerix to Present at Credit Suisse 30th Annual Healthcare Conference GlobeNewswire
Oct-29-21 10:36AM	Hedge Funds Are Piling Into Chimerix Inc (CMRX) Insider Monkey
Oct-28-21 03:05PM	Analysts Estimate Chimerix (CMRX) to Report a Decline in Earnings: What to Look Out for Zacks
07:00AM	Chimerix to Report Third Quarter 2021 Financial Results and Provide an Operational Update on November 4, 2021 GlobeNewswire
Sep-07-21 07:00AM	Chimerix to Present at H.C. Wainwright 23rd Annual Global Investment Conference GlobeNewswire
Aug-07-21 06:01AM	Chimerix (CMRX) Q2 2021 Earnings Call Transcript Motley Fool
Aug-06-21 02:18AM	Did You Miss Chimerix's (NASDAQ:CMRX) Impressive 108% Share Price Gain? Simply Wall St.
Aug-05-21 07:00AM	Chimerix Reports Second Quarter 2021 Financial Results and Provides Operational Update GlobeNewswire
Aug-03-21 07:00AM	Chimerix to Present at 2021 Wedbush PacGrow Healthcare Conference GlobeNewswire
Jul-29-21 07:00AM	Chimerix to Report Second Quarter 2021 Financial Results and Provide an Operational Update on August 5, 2021 GlobeNewswire
Jul-27-21 06:48PM	Were Hedge Funds Right About Chimerix Inc (CMRX)? Insider Monkey
Jul-01-21 06:58AM	Trade Alert: The Independent Director Of Chimerix, Inc. (NASDAQ:CMRX), Fred Middleton, Has Just Spent US$78k Buying 5.1% More Shares Simply Wall St. +9.38%
Jun-04-21 02:10PM	Chimerix Receives U.S. Food and Drug Administration Approval for TEMBEXA® (brincidofovir) for the Treatment of Smallpox GlobeNewswire
May-25-21 08:00AM	Chimerix to Present at Jefferies Virtual Healthcare Conference GlobeNewswire
May-24-21 02:04AM	Chimerix (NASDAQ:CMRX) Has Debt But No Earnings; Should You Worry? Simply Wall St.
May-19-21 05:01PM	Chimerix Announces Upcoming Presentations at the American Society of Clinical Oncology 2021 Annual Meeting GlobeNewswire
May-13-21 07:00AM	Chimerix to Present at Cowen and Company 2nd Annual Virtual Oncology Innovation Summit GlobeNewswire
May-07-21 09:01AM	Chimerix (CMRX) Q1 2021 Earnings Call Transcript Motley Fool
May-06-21 07:00AM	Chimerix Reports First Quarter 2021 Financial Results and Provides Operational Update GlobeNewswire
May-05-21 06:40AM	Chimerix (CMRX) Sees Hammer Chart Pattern: Time to Buy? Zacks
Apr-29-21 07:00AM	Chimerix to Report First Quarter 2021 Financial Results and Provide an Operational Update on May 6, 2021 GlobeNewswire
Apr-28-21 11:43AM	Owens & Minor (OMI) to Report Q1 Earnings: What's in Store? Zacks
Apr-26-21 07:00AM	Chimerix Appoints Vicki Vakiener to Board of Directors GlobeNewswire
Apr-08-21 04:01PM	Chimerix Announces Upcoming Presentations at the American Association for Cancer Research Annual Meeting 2021 GlobeNewswire
02:15AM	What Kind Of Shareholders Hold The Majority In Chimerix, Inc.'s (NASDAQ:CMRX) Shares? Simply Wall St.
Mar-02-21 07:00AM	Chimerix to Present at Virtual H.C. Wainwright Global Life Sciences Conference GlobeNewswire +6.63%
Feb-26-21 01:44PM	Chimerix, Exclusive Worldwide Licensee of Cantex's Investigational Product, DSTAT, Has Announced Promising Topline Results from the First Cohort of a Randomized COVID-19 Clinical Trial PR Newswire -8.06%
Feb-25-21 11:31PM	Chimerix (CMRX) Q4 2020 Earnings Call Transcript Motley Fool
08:50AM	Chimerix's DSTAT Shows Promising Results In First Cohort Of COVID-19 Study Benzinga
08:08AM	The Daily Biotech Pulse: Merck Goes Shopping, Decision Day For Sarepta, Pfizer, Moderna Unveil Vaccine Strategies For Coronavirus Variants Benzinga
07:00AM	Chimerix Reports Promising Topline Results from First Cohort of a Randomized COVID-19 Trial with DSTAT GlobeNewswire
07:00AM	Chimerix Reports Fourth Quarter and Year End 2020 Financial Results and Provides Operational Update GlobeNewswire
06:30AM	Chimerix, Inc. to Host Earnings Call ACCESSWIRE
Feb-18-21 07:00AM	Chimerix to Report Fourth Quarter and Year End 2020 Financial Results and Provide an Operational Update on February 25, 2021 GlobeNewswire -8.09%
Jan-25-21 05:44PM	Chimerix Announces Closing of Public Offering of Common Stock and Full Exercise of Option to Purchase Additional Shares GlobeNewswire
Jan-20-21 08:03PM	Chimerix Announces Pricing of Public Offering of Common Stock GlobeNewswire +12.72%
Jan-19-21 04:19PM	Chimerix Announces Proposed $75,000,000 Public Offering of Common Stock GlobeNewswire
Jan-11-21 10:29AM	Company News for Jan 11, 2021 Zacks
Jan-08-21 07:48PM	Why Chimerix Stock Skyrocketed on Friday Motley Fool +69.08%
04:25PM	TripAdvisor, Acacia, WD-40: 5 Top Stock Gainers for Friday TheStreet.com
07:25AM	The Daily Biotech Pulse: Sarepta Gene Therapy Study Readout, Novavax Vaccine Supply Deal, 2 IPOs Benzinga
06:00AM	Chimerix Acquires Oncoceutics to Expand Pipeline with Late-Stage Oncology Program GlobeNewswire
Jan-06-21 08:00AM	Chimerix to Present at Virtual H.C. Wainwright BioConnect 2021 Conference GlobeNewswire
Dec-22-20 12:41AM	Did Business Growth Power Chimerix's (NASDAQ:CMRX) Share Price Gain of 141%? Simply Wall St.
Dec-12-20 10:30PM	Is CMRX A Good Stock To Buy Now? Insider Monkey
Dec-08-20 08:56AM	Chimerx's (CMRX) NDA for Brincidofovir Accepted by FDA Zacks +12.33%
Dec-07-20 07:00AM	Chimerix Announces FDA Acceptance of New Drug Application for Brincidofovir as a Medical Countermeasure for Smallpox GlobeNewswire +25.41%
Nov-07-20 08:33AM	Analysts Have Lowered Expectations For Chimerix, Inc. (NASDAQ:CMRX) After Its Latest Results Simply Wall St.
Nov-06-20 05:50AM	Revenue Downgrade: Here's What Analysts Forecast For Chimerix, Inc. (NASDAQ:CMRX) Simply Wall St.
Nov-05-20 04:01PM	Chimerix to Present at Credit Suisse 29th Annual Healthcare Conference GlobeNewswire
07:00AM	Chimerix Reports Third Quarter 2020 Financial Results and Provides Operational Update GlobeNewswire
Oct-29-20 07:00AM	Chimerix to Report Third Quarter 2020 Financial Results and Provide an Operational Update on November 5, 2020 GlobeNewswire
Oct-28-20 08:12AM	Did Chimerix, Inc. (NASDAQ:CMRX) Insiders Buy Up More Shares? Simply Wall St.
Sep-13-20 10:21AM	What Kind Of Shareholders Own Chimerix, Inc. (NASDAQ:CMRX)? Simply Wall St.
Sep-10-20 08:00AM	Chimerix to Participate in Upcoming Investor Conferences GlobeNewswire
Aug-10-20 08:25AM	Chimerix (CMRX) Reports Q2 Loss, Tops Revenue Estimates Zacks
07:28AM	Recap: Chimerix Q2 Earnings Benzinga
07:00AM	Chimerix Reports Second Quarter 2020 Financial Results and Provides Operational Update GlobeNewswire
Aug-03-20 08:00AM	Chimerix to Report Second Quarter 2020 Financial Results and Provide an Operational Update on August 10, 2020 GlobeNewswire
Jul-15-20 12:22PM	Will Chimerix (NASDAQ:CMRX) Spend Its Cash Wisely? Simply Wall St. +7.31%
Jul-05-20 02:43PM	Here is What Hedge Funds Think About Chimerix Inc (CMRX) Insider Monkey
Jun-22-20 07:00AM	Chimerix Appoints Allen Melemed, M.D. as Chief Medical Officer GlobeNewswire +5.79%
Jun-18-20 08:00AM	Chimerix to Present at H.C. Wainwright Virtual Fireside Chat Series GlobeNewswire
May-28-20 08:00AM	Chimerix to Present at Jefferies Virtual Healthcare Conference GlobeNewswire -9.66%
May-12-20 06:47AM	Revenue Downgrade: Here's What Analysts Forecast For Chimerix, Inc. (NASDAQ:CMRX) Simply Wall St.
May-07-20 10:25AM	Chimerix (CMRX) Reports Q1 Loss, Lags Revenue Estimates Zacks +9.52%
09:07AM	Recap: Chimerix Q1 Earnings Benzinga
07:00AM	Chimerix Reports First Quarter 2020 Financial Results and Provides Operational Update GlobeNewswire
May-02-20 08:40AM	One Thing To Remember About The Chimerix, Inc. (NASDAQ:CMRX) Share Price Simply Wall St.
Apr-29-20 07:00AM	Chimerix Announces Initiation of a Phase 2/3 Study of DSTAT in Acute Lung Injury for Patients with Severe COVID-19 GlobeNewswire +42.38%
Apr-28-20 04:30PM	Chimerix Receives FDA Clearance for Rolling Submission of New Drug Application for Brincidofovir as a Medical Countermeasure for Smallpox GlobeNewswire
Mar-26-20 08:18AM	Edited Transcript of CMRX earnings conference call or presentation 25-Feb-20 1:30pm GMT Thomson Reuters StreetEvents +7.86%
Mar-18-20 06:26AM	Michael Sherman Is The CEO, President & Director of Chimerix, Inc. (NASDAQ:CMRX) And They Just Spent US$106k On Shares Simply Wall St. -15.89%
Feb-28-20 12:00PM	All You Need to Know About Chimerix (CMRX) Rating Upgrade to Buy Zacks
Feb-26-20 08:00AM	Chimerix to Present at Cowen and Company 40th Annual Health Care Conference GlobeNewswire -7.00%
Feb-25-20 07:00AM	Chimerix Reports Fourth Quarter and Year End 2019 Financial Results and Provides Operational Update GlobeNewswire +15.61%
06:30AM	Chimerix, Inc. to Host Earnings Call ACCESSWIRE
Feb-24-20 08:00AM	Chimerix Appoints Pratik S. Multani, M.D., to Board of Directors GlobeNewswire
Feb-18-20 08:00AM	Chimerix to Report Fourth Quarter and Year End 2019 Financial Results and Provide an Operational Update on February 25, 2020 GlobeNewswire +5.39%
Feb-06-20 07:04AM	Investors Who Bought Chimerix (NASDAQ:CMRX) Shares Five Years Ago Are Now Down 96% Simply Wall St.
Feb-05-20 11:52AM	Steven Cohen Renews His Interest in Verastem GuruFocus.com
Jan-29-20 08:00AM	Chimerix Presents Data Supporting Brincidofovir as a Potential Treatment for Smallpox at 2020 American Society for Microbiology Biothreats Meeting GlobeNewswire
Jan-03-20 11:30AM	Has Chimerix (CMRX) Outpaced Other Medical Stocks This Year? Zacks +7.18%
Dec-23-19 06:12AM	Here's Why We're Watching Chimerix's (NASDAQ:CMRX) Cash Burn Situation Simply Wall St.
Dec-16-19 01:04AM	New Trade Deal, New Records for S&P and NASDAQ Zacks
Dec-14-19 08:59PM	Is Chimerix Inc (CMRX) A Good Stock To Buy? Insider Monkey
Dec-10-19 07:30AM	Chimerix Presents Updated Results from Phase 2 Clinical Trial of DSTAT in Refractory Myelodysplastic Syndrome and Acute Myeloid Leukemia at American Society of Hematology Annual Meeting GlobeNewswire -20.16%
Dec-04-19 01:01AM	Stocks Not Happy About Talk of Trade Deal Delay Zacks -6.99%
Nov-22-19 12:02AM	Edited Transcript of CMRX earnings conference call or presentation 5-Nov-19 1:30pm GMT Thomson Reuters StreetEvents
Nov-07-19 06:19AM	Should You Be Concerned About Chimerix, Inc.'s (NASDAQ:CMRX) Historical Volatility? Simply Wall St. +6.49%
Nov-05-19 07:00AM	Chimerix Announces Third Quarter 2019 Financial Results and Provides Operational Update GlobeNewswire +8.22%
Nov-04-19 04:01PM	Chimerix to Present at Upcoming Investor Conferences GlobeNewswire -7.01%

Chimerix, Inc., a development-stage biopharmaceutical company, focuses on accelerating the advancement of various medicines that impact in the lives of patients living with cancer and other serious diseases. Its clinical stage development programs include brincidofovir (BCV), an antiviral drug candidate in development as a medical countermeasure for smallpox; dociparstat sodium (DSTAT), which inhibits the activities of key proteins implicated in the resistance of acute myeloid leukemia blasts and leukemic stem cells to chemotherapy; and ONC201 a program for potentially treating tumors which harbor the H3 K27M mutation in recurrent diffuse midline glioma patients. The company has license agreements with Biomedical Advanced Research and Development Authority for the development of brincidofovir for use in the treatment of smallpox; Cantex Pharmaceuticals, Inc. to develop and commercialize a glycosaminoglycan compound; and SymBio Pharmaceuticals to develop, manufacture, and commercialize BCV for various human indications. Chimerix, Inc. was incorporated in 2000 and is headquartered in Durham, North Carolina.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Jakeman David	Principal Accounting Officer	Sep 30	Sale	6.19	4,590	28,412	106,066	Sep 30 06:02 PM
CANTEX PHARMACEUTICALS, INC.	10% Owner	Sep 14	Sale	5.75	6,500,000	37,375,000	3,500,000	Sep 16 04:05 PM
MIDDLETON FRED A	Director	Jun 28	Buy	7.83	6,950	54,418	207,523	Jun 29 05:37 PM
MIDDLETON FRED A	Director	Jun 25	Buy	7.78	3,050	23,729	200,573	Jun 29 05:37 PM
Jakeman David	Principal Accounting Officer	Apr 05	Option Exercise	2.35	5,250	12,338	103,989	Apr 07 01:37 PM
Jakeman David	Principal Accounting Officer	Apr 05	Sale	9.68	1,284	12,427	102,705	Apr 07 01:37 PM
Meyer Robert J.	Director	Mar 01	Buy	9.80	1,500	14,700	15,000	Mar 01 02:10 PM
Jakeman David	Principal Accounting Officer	Jan 28	Sale	8.61	3,211	27,650	96,906	Jan 29 08:13 PM

open in yahoo | open in reuters | open in marketwatch | open in google

Upgrade your FINVIZ experience